Tendon and Bone Cellular Therapies

Qsports Medicine is a world leading medical practice in the use of cellular therapies. Within ten years, these therapies are likely to revolutionise the treatment of sports and musculoskeletal injuries.
Our current clinical trials include:

• Pilot study in the use of autologous tenocyte implantation (ATI) in the treatment of gluteus medius and minimus tendinopathy.
  (Investigators: Dr M Young, Dr P Weinrauch, Dr G Cowderoy, Dr A Grimaldi)
  
  
• Phase 1 trial in the use of allogeneic mesenchymal stem cells in the treatment of refractory Achilles tendinopathy [ACTRN12610000985088].
  This is a world first trial and is being undertaken at the Mater Medical Research Institute, Brisbane.
  (Investigators: Dr M Young, Prof K Atkinson, Dr R Brown, Queensland X-Ray – Dr P Lush)
  Status – Recruiting. Further information….
  
  
• Proposed: Phase 1 trial in the use of allogeneic mesenchymal stem cells in the treatment of fracture non-unions.
  (Investigators: Dr M Young, Prof K Atkinson, Dr J Radovanovic and Dr C Cooke)
  
  
• Proposed: Phase 1 trial in the use of allogeneic mesenchymal stem cells in the treatment of critical bone defects.
  (Investigators: Dr M Young, Prof K Atkinson, Dr J Radovanovic and Dr C Cooke).

If you are interested in participating in a volunteer trial for the treatment of chronic achilles tendinitis at the Mater hospital in Brisbane.
Click to view a document outling the requirements for participation in the volunteer trial.
It also contains more details of the proposed treatment and contact details.



Back to Information Sheets
More on the treatment of lower limb tendinopathy.